ESG News For Viatris

AMR impacts everyone and has multiple drivers. Its causes and effects are complex and affect populations unevenly across the globe. And because of climate change, the problem is getting worse.

Leo's pharmaceutical career began unexpectedly when a friend leaving for military service asked him to fill his role at one of Viatris' legacy companies.

Viatris is committed to reducing absolute scope 1 and 2 GHG emissions by 42% and absolute scope 3 GHG emissions by 25%, in each case by 2030 from a 2020 baseline year.

With a large footprint in India, we have a broad program supporting communities there.

We are continuously looking for ways to reduce the volume and types of materials being used in packaging while safeguarding access to high-quality medicines and maintaining compliance with various regulatory and quality requirements around the world.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024.

Across all locations, we are committed to protecting contractors and visitors. They are covered by site-specific EHS policies and procedures, and we track the safety performance of our contractors through established guidelines, pre-screening and training.

With a global workforce in a variety of settings including offices, laboratories and manufacturing plants, maintaining a safe and healthy workplace for our Viatris colleagues regardless of their location is imperative.

In addition to packaging operations, Viatris’ Komárom site is also home to the European Center of Excellence, the company’s largest Quality organization in the region. The location has a long history of commitment to advancing sustainability.

Today, those words of advice still resonate with Karen, who is Viatris’ Head of Compliance for Japan, Australia, New Zealand and South Korea. And they remind her of how many women have had to become overachievers just to secure their place in the world.

With people at the heart of our mission, Viatris is committed to representing and capturing the diverse voices of patients and caregivers and joining together for advocacy.

We leverage our global experiences, scientific expertise and operations knowledge to support policymakers in identifying policies that advance access to quality medicines and build systems that sustain availability while minimizing unintended consequences.

At Viatris, we have expanded access at scale to high-quality HIV/AIDS treatment for more than a decade. Our work includes helping to prevent HIV infections, increasing diagnosis and treatment and providing healthcare solutions.

In 2023, NCDs continued to dominate as the leading causes of death globally according to WHO, accounting for about 74% of all deaths. Of those approximately 41 million deaths, 77% occur in LMICs, adding to the dual burden of NCD and infectious disease.

Health systems can only function with health workers. One of the greatest global hurdles in achieving equitable access to treatment and promoting good health is the growing gap in supply and demand for healthcare workers.

As an essential business, Viatris has taken actions to maintain a reliable supply of medicines, with special measures around critical medicines in times of volatile demand.

Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthcare needs globally.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's World's Most Sustainable Companies 2024.

For many people, accessing the medicines they need is a matter of picking up a prescription at a pharmacy or hospital. But what many don’t see is the intricate ecosystem that works to get the right medicine to them, at the right place, at the right time.

Viatris’ Global Device Development team is responsible for end-to-end development and commercialization for device and combination products, including pens and auto-injectors, inhalers, as well as complex and branded generic drugs.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today published its 2023 Sustainability Report: Building Sustainable Access at Scale.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has donated more than 7 million doses of medicine to its long-standing partner Direct Relief to support humanitarian medical relief efforts across the world.

Viatris’ Indore manufacturing site has received certification for International Sustainability Rating System (ISRS), 9th Edition – Process Safety, from DNV, a global service provider for managing risk and supporting safe and responsible business performance.

While still driving for Viatris, Happiness earned greater responsibilities in office services management. He took the opportunity to sit in company sales and training meetings while waiting for the executives that he’d driven to the meeting, listening attentively to learn more.

As the co-chair of EmpoWer, Viatris’ employee resource group for women and their allies, she sees a sense of belonging and inclusion as one of the unifying characteristics of the membership.

At Viatris, we work to help people worldwide live healthier at every stage of life. We strive to put the person at the center of their own unique health journey by providing access to high-quality medicines and healthcare solutions.

In January 2024, Viatris was notified that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR).

That is why we are kicking off a program to listen to and engage with colleagues across the company on this topic: how access impacts each of us, our families and our communities globally. We are calling this initiative Access Conversations.

When Olebogeng Moumakwe strides through the maze of streets that weave through Diepsloot, people often call out to her in recognition – whether she remembers them or not.

When the clinic first opened – built with funds provided by Viatris in partnership with Rhiza Babuyile, a local nonprofit – Sister Thandi cried.